Last Updated: May 10, 2026

Details for Patent: 7,118,552


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,118,552
Title:Automatically operable safety shield system for syringes
Abstract:An automatically operable safety shield system for use with a syringe, the safety shield system including an holder having proximal and distal portions and defining an enclosure into which the syringe may be inserted, an outer shield having proximal and distal portions, mounted outwards from the inner holder being axially movable relative to the inner holder between retracted and extended positions, a spring positioned between a first detent on the inner holder and a second detent on the outer shield, and urging the outer shield to its extended position, the inner holder having at least one first opening and the outer shield having at least one first stop member, the first stop member being engageable with the first opening when the outer shield is in the retracted position, the inner holder having distal to the first opening at least one first indentation, the first stop member being engageable with the first indentation when the outer shield is in the extended position.
Inventor(s):Derek J. Shaw, Brian R. Law
Assignee: Tersera Therapeutics LLC
Application Number:US09/936,859
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Scope, claims, and US patent landscape for US Patent 7,118,552

US 7,118,552 is directed to a mechanically actuated, automatically operable needle safety shield for a syringe. The invention integrates: (1) an inner holder that captures the syringe; (2) an outer axially movable shield biased by a spring; (3) a stop-and-indentation latch that retains the shield in a retracted state until a trigger event occurs; and (4) a trigger that is contacted and disengaged by a syringe component, so the spring drives the outer shield to an extended (needle-covering) position.

What the independent claim actually requires (Claim 1)

Claim 1 is the core mechanical recipe. It requires all of the following, in combination:

  1. Inner holder with proximal and distal portions, defining an enclosure for insertion of a syringe.
  2. Outer shield with proximal and distal portions, mounted outward of the inner holder and axially movable relative to the inner holder between:
    • retracted position (needle initially exposed), and
    • extended position (needle covered).
  3. Spring bias positioned between:
    • a first detent on the inner holder and
    • a second detent on the outer shield, urging the outer shield to the extended position.
  4. Retaining latch in retracted state:
    • inner holder has at least one first opening;
    • outer shield has at least one first stop member that is engageable with the first opening when the outer shield is retracted.
  5. Positive latch engagement in extended state:
    • inner holder has at least one first indentation located distal to the first opening;
    • the first stop member is engageable with the first indentation when the outer shield is extended.
  6. Trigger positioned within the inner holder, axially movable relative to the inner holder:
    • it can contact the first stop member when engaged with the first opening, and
    • it can disengage the first stop member from the first opening, which allows the spring to move the outer shield to the extended position.

Interpretation for scope: Claim 1 is not a generic “safety shield.” It is a specific axial slide + spring + latch architecture where the outer shield’s extension is released by a trigger that mechanically disengages a stop member from an opening during syringe use.


Claim-by-claim scope map (what is broadened, constrained, or added)

Below is how dependent claims tighten or expand the mechanical coverage.

Claim 2

  • Places the first and second detents specifically on the distal portions of the inner holder and outer shield.

Scope effect: narrows detent placement but keeps the same latch logic.

Claim 3

  • Adds a specific syringe coupling: the safety system includes a syringe with:
    • barrel, needle, piston, plunger rod
    • plunger rod has a protrusion
  • The syringe is operationally coupled to the trigger such that movement of the plunger rod protrusion contacts the trigger to:
    • disengage the first stop member from the first opening
    • allow spring-driven extension.

Scope effect: defines the release interface as a plunger-rod-driven protrusion contacting the trigger.

Claim 4 (independent-style apparatus claim)

  • Recasts the system with the coupling language moved into a full system claim:
    • syringe with plunger protrusion
    • inner holder/outer shield axial movement
    • spring between distal detents
    • opening/stop member engagement in retracted state
    • indentation engagement in extended state
    • plunger protrusion contacts trigger to disengage stop member.

Scope effect: covers the same concept in a different claim grammar. Practically, it reinforces claim coverage over the complete syringe-actuation mechanism.

Claim 5

  • Adds a safety clip removably secured to the portion of the plunger rod exposed from the barrel.
  • When secured, movement of the plunger rod is prevented.

Scope effect: limits to embodiments with a removable pre-use lock.

Claim 6

  • Requires proximal and distal abutment surfaces on outer shield and inner holder in opposing relationship.
  • These abutment surfaces prevent the outer shield from moving beyond the extended position.

Scope effect: adds a hard stop to limit shield travel.

Claims 7–8

  • Outer/inner holders are generally cylindrical with cross-section circular or elliptical (Claim 7).
  • The cylindrical shape can be tapered cylindrical (Claim 8).

Scope effect: constrains geometry but preserves the mechanism.

Claims 9–13 (anti-rotation guidance and sliding features)

  • Guide means prevent relative rotation of inner holder and outer shield (Claim 9).
  • The inner holder includes a groove corresponding to the stop member so the stop member is slidable (Claim 10 or 12 depending on which inner/outer feature used).
  • The outer shield includes grooves corresponding to distal abutment surfaces so those surfaces are slidable (Claim 13).

Scope effect: narrows to embodiments with guided axial motion and defined sliding paths for the stop member and abutment surfaces.

Claim 14

  • Adds an inner holder detent: radially inwardly extending distal flange with an upper abutment surface contacted by the syringe to prevent further distal movement of the syringe.

Scope effect: addresses syringe insertion depth and retention behavior.

Claim 15

  • Requires syringe engagement and retaining means within the inner holder.

Scope effect: adds retention features.

Claims 16–18 (grip geometry)

  • Claim 16: finger grip via at least one radially extending protrusion at proximal end.
  • Claim 17: protrusion is a flange around full circumference.
  • Claim 18: outer shield lacks proximal finger grip protrusions.

Scope effect: limits ergonomic features.

Claims 19–20 (anti-backward movement and stop member geometry)

  • Claim 19: includes plunger rod retaining means preventing backwards movement when the plunger rod is “at least almost at its forwardmost position.”
  • Claim 20: stop member extends outwardly then inwardly such that the center of its pivotal axis is inward of the point of engagement with the first opening when engaged.

Scope effect: adds a kinematic geometry detail to the stop member.


What design elements are “must-have” vs “optional”

Must-have under Claim 1 (core coverage)

  • Outer shield axially movable and biased by a spring
  • A latch that holds the outer shield in retracted state:
    • first stop member engages first opening in the inner holder
  • A release trigger inside inner holder that:
    • contacts the first stop member when engaged with the opening
    • disengages the stop member from the opening
  • A second latch engagement in extended state:
    • first stop member engages indentation distal to the opening
  • Trigger release is triggered by user syringe operation either explicitly in dependent claims (Claim 3/4) or implied by the trigger being contactable during operation.

Optional / further limitations (dependent claims)

  • Detent placement (Claim 2 and Claim 4)
  • Specific syringe structure and protrusion-to-trigger coupling (Claims 3 and 4)
  • Safety clip (Claim 5)
  • Travel-limiting abutment surfaces (Claim 6)
  • Cylindrical/tapered shape and anti-rotation grooves (Claims 7–13)
  • Syringe insertion stop flange and retention means (Claims 14–15)
  • Finger grip and ergonomics (Claims 16–18)
  • Plunger rod backward prevention (Claim 19)
  • Specific stop member pivot-axis offset geometry (Claim 20)

Claim scope pressure points (where design-arounds typically succeed)

The patent landscape for needle safety devices usually turns on how the shield is retained and released. For US 7,118,552 specifically, the highest-risk elements for an infringing design are:

  1. Stop member that engages an opening in retracted position and then engages an indentation in the extended position.
  2. A trigger that is axially movable inside the inner holder and that disengages the stop member from the opening.
  3. Axial movement of the outer shield relative to the inner holder (not radial swing).
  4. Spring-driven extension after latch release.

Design alternatives that keep the same functional safety outcome but change the kinematics can reduce risk:

  • Using a different retention geometry (for example, retention by friction brake rather than a stop member engaged in an opening).
  • Using a different release mechanism (for example, release by a cam or a pivoting lever that does not disengage a stop member from a first opening).
  • Using a different motion type (radial or rotational deployment rather than axial slide).

Those are not “guaranteed” outcomes against any given claim set, but they are the structural features Claim 1 appears to require.


US patent landscape context (device-class neighborhood around axial spring-loaded shields)

US 7,118,552 sits in the crowded needle safety “device” space, where most patents involve:

  • a cover/shield moved between needle-exposed and needle-covered states,
  • a user-actuated lock-release event,
  • an internal latch mechanism tied to syringe motion.

Given the mechanical specificity of Claim 1, the most relevant landscape for freedom-to-operate assessment is dominated by axially deployed safety sleeves with internal latch triggers. Companies typically file improvements around:

  • latch geometry (openings/indentations, detents, ratchets)
  • coupling to plunger rod travel (protrusion, clip locks, trigger rods)
  • anti-backslide and travel-limiting abutments
  • guided axial motion to avoid rotation and maintain alignment

Operational conclusion for R&D and design: if a competing product uses axial sleeve deployment, then the key differentiator becomes the exact latch-release architecture. If the competing product uses the same type of opening/indentation stop-member engagement with an internal axial trigger, the likelihood of claim overlap rises sharply.


Competitive and investment implications

If you are licensing or acquiring: what the claims suggest about value

  • The invention’s value concentrates in a repeatable mechanical latch-and-trigger architecture rather than in a single ergonomic feature.
  • Dependent claims extend enforceability into practical product variants:
    • detent placements,
    • syringe protrusion coupling,
    • safety clip pre-lock,
    • travel stops,
    • guide features.

If you are developing a “next-gen” platform: where to innovate

  • Change how the release event occurs without using the same “stop member disengaged from a first opening by an internal axial trigger.”
  • Keep deployment safety compliance while shifting geometry:
    • latch architecture,
    • motion type,
    • release interface.

Key Takeaways

  • US 7,118,552 claims a spring-biased, axially sliding safety shield held by a stop member that engages an opening in retracted state and an indentation in extended state.
  • A trigger axially movable inside the inner holder contacts and disengages the stop member from the opening, enabling spring-driven extension.
  • Dependent claims add enforceable product features: plunger rod protrusion coupling, safety clip pre-lock, travel-limiting abutment surfaces, anti-rotation guidance, syringe insertion stop, and anti-backslide.
  • The infringement-risk hotspots are the opening/indentation stop-member latch and the internal axial trigger disengagement sequence tied to syringe actuation.

FAQs

1) Is Claim 1 limited to a specific syringe model?

Claim 1 requires a system “for use with a syringe” and a trigger mechanism that can contact and disengage the first stop member. Claim 1 does not fully lock in the specific syringe component geometry; Claims 3 and 4 add the plunger rod protrusion coupling and syringe element structure.

2) Does the patent cover both retracted and extended latch states?

Yes. Claim 1 requires that the first stop member engages a first opening when retracted and engages a first indentation when extended, creating a two-state latch architecture.

3) What motion does the outer shield use?

Claim 1 requires axial movement between retracted and extended positions. The outer shield moves axially relative to the inner holder.

4) What triggers the release of the shield?

Claim 1 requires an internal, axially movable trigger that disengages the stop member from the first opening. Claims 3 and 4 define a syringe actuation link where a plunger rod protrusion contacts the trigger.

5) Which dependent claims most affect product implementation?

Claim 3/4 (plunger protrusion coupling), Claim 5 (safety clip), Claim 6 (abutment travel stop), Claims 9–13 (anti-rotation and grooves), and Claim 19–20 (anti-backslide and stop-member pivot-axis geometry) most directly map to engineering design choices.


References

[1] US Patent 7,118,552. “Automatically operable safety shield system for use with a syringe.” (Claims provided in user prompt).

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 7,118,552

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,118,552

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0003790Feb 18, 2000
PCT Information
PCT FiledFebruary 13, 2001PCT Application Number:PCT/GB01/00590
PCT Publication Date:August 23, 2001PCT Publication Number: WO01/60435

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.